Technical Analysis for TMDX - TransMedics Group, Inc.

Grade Last Price % Change Price Change
B 138.62 0.46% 0.64
TMDX closed up 0.46 percent on Monday, May 20, 2024, on 46 percent of normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Very Strong Up Up Up

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
New 52 Week High Strength 0.00%
Multiple of Ten Bearish Other 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
New 52 Week Closing High Bullish 0.46%
New 52 Week High Strength 0.46%
Wide Bands Range Expansion 0.46%
Overbought Stochastic Strength 0.46%
NR7 Range Contraction 2.73%

   Recent Intraday Alerts

Alert Time
Rose Above Previous Day's High about 15 hours ago
New 52 Week High about 15 hours ago
Up 1% about 17 hours ago
Down 1% about 17 hours ago
60 Minute Opening Range Breakout 4 days ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

TransMedics Group, Inc. Description

TransMedics, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. The company offers Organ Care System (OCS), an integrated, compact, portable preservation technology that addresses unmet need for organs for transplantation. Its Organ Care System preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure. Its Organ Care System incudes OCS LUNG, a portable perfusion, ventilation, and monitoring system that maintains organs in a near physiologic state and enables surgeons to perfuse and ventilate the organ between the donor and recipient sites; OCS Heart, a portable heart perfusion system that helps to maintain organs in a warm functioning state outside of the body; and OCS Liver, a portable perfusion and monitoring system that maintains organs in a near physiologic state. The company offers its products in the United States and internationally. TransMedics, Inc. is headquartered in Andover, Massachusetts. TransMedics, Inc. is a subsidiary of Transmedics Group, Inc.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Disease Surgery IBD 50 Medical Technology Transplantation Organs Perfusion Transplantation Medicine Organ Failure Organ Transplantation Organ Transplant

Is TMDX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 140.2632
52 Week Low 36.4201
Average Volume 920,052
200-Day Moving Average 75.35
50-Day Moving Average 96.48
20-Day Moving Average 119.01
10-Day Moving Average 132.54
Average True Range 5.88
RSI (14) 78.72
ADX 56.56
+DI 39.19
-DI 5.19
Chandelier Exit (Long, 3 ATRs) 122.63
Chandelier Exit (Short, 3 ATRs) 100.51
Upper Bollinger Bands 155.65
Lower Bollinger Band 82.38
Percent B (%b) 0.77
BandWidth 61.56
MACD Line 12.53
MACD Signal Line 11.73
MACD Histogram 0.802
Fundamentals Value
Market Cap 4.53 Billion
Num Shares 32.6 Million
EPS -1.09
Price-to-Earnings (P/E) Ratio -127.17
Price-to-Sales 15.17
Price-to-Book 22.90
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 144.49
Resistance 3 (R3) 144.39 142.32 143.51
Resistance 2 (R2) 142.32 140.83 142.38 143.19
Resistance 1 (R1) 140.47 139.91 141.40 140.58 142.86
Pivot Point 138.41 138.41 138.87 138.46 138.41
Support 1 (S1) 136.56 136.92 137.49 136.66 134.38
Support 2 (S2) 134.50 135.99 134.55 134.05
Support 3 (S3) 132.65 134.50 133.73
Support 4 (S4) 132.75